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Compartmentalization of tissue RAS
Clearly, it has to be established how the tissue systems, and The renin-angiotensin system the responses of the angiotensin receptors, are maintained separately from systemic events. In some cases there may be Classically, the renin-angiotensin system (RAS) has been described in terms of the systemic blood-borne system (Peach, physical barriers, for example, the blood-brain or blood-testis barriers (Ehlers and Riordan, 1989) , limiting the availability 1977; Vallotton, 1987; Vinson et al., 1995a) . Its components act in combination to form the active hormone angiotensin II of plasma angiotensin II.
However, although precise data on the cellular localizations in the bloodstream. The precursor molecule preprorenin is translated in the juxtaglomerular cells of the kidney, and the of the sites of production of the RAS components, and their relationship to the sites of angiotensin II action, are not signal peptide is cleaved, forming prorenin. This may be acted upon by prorenin convertase to yield the active proteolytic available for all tissues (Mulrow, 1992; Phillips et al., 1993) , at least some evidence exists, for example in the adrenal, the enzyme renin. The kidney is the source of renin secreted into the bloodstream, but prorenin is also present in plasma and is Leydig cell, and in the epididymis, to suggest that the angiotensin II-responsive cells themselves may be the source of secreted by the kidney, and also by other tissues, leading to some speculation that unconverted prorenin may itself have angiotensin II (Pandey et al., 1984; Urata et al., 1994a; Zhao et al., 1996) . This raises other questions: if one cell type is biological activity (Sealey and Rubattu, 1989; Ganong, 1995; Sealey et al., 1996) . Active renin in turn cleaves a plasma both the source of angiotensin II and its site of action, what implications does this hold for receptor occupancy, and the protein substrate, angiotensinogen, an α 2 -globulin, to yield the decapeptide angiotensin I. Two amino acids from the carboxyl cell's capacity to respond to further, systemic, angiotensin II stimulation? One possibility is that angiotensin receptors are terminus of this peptide are removed by the metalloenzyme angiotensin converting enzyme (ACE), thus producing the in some way sequestered intracellularly so that their availability to locally generated angiotensin II can be regulated. active octapeptide hormone angiotensin II. Other enzymes may cell death, apoptosis (Yamada et al., 1996) , leading to the view that the tissue modelling role of angiotensin II reflects the antagonism between the AT1 receptor subtype, which stimulates mitosis in many cell types McEwan et al., 1996) , and the AT2 receptor.
There are significant variations in the tissue distribution of the AT1 and AT2 receptors. In the rat adrenal, most of those in the glomerulosa are AT1 type, while those in the medulla are mostly AT2: only AT1 receptors were detected in the bovine adrenal cortex (Balla et al., 1991) . The non-pregnant human uterus expresses mostly AT2 receptors (but see below), while the rat uterus also contains AT1. Both AT1 and AT2 receptors are present in rat brain, but the AT2 receptor concentration is particularly high in neonatal newborn and young animals (Millan et al., 1991; Tsutsumi and Saavedra, 1991) . Predominantly AT2 receptors are expressed in rat and bovine ovary Aiyar et al., 1993) , while other tissues contain both AT1 and AT2 subtypes in varying proportions (Montiel et al., 1993) .
Receptor isoforms and receptor internalization
Studies from our laboratory also gave direct evidence for additional angiotensin II binding protein subtypes in the One level of complexity lies in the distribution of receptor subtypes, which is clearly related to their specific cellular rat adrenal gland and other tissues. Using high-resolution isoelectric focusing (IEF), we observed four peaks of specific functions, but which, because of differences in affinity or location of expression, may conceivably have a role in discrim-125 I-labelled angiotensin II binding which migrate at isoelectric points (pI) 7.0, 6.8, 6.5 and 6.3. All four are found in the rat inating between systemic and tissue RAS activity. Two subtypes are classified as AT1 and AT2, according to their sensitivity adrenal, but are variably expressed in other tissues (Jimenez et al., 1991) . Use of non-peptide antagonists and comparison to the angiotensin II antagonists losartan (AT1 selective) and CGP42112 or PD123177 (AT2 selective) (Wong et al., 1990a;  with COS-7 cell expressed AT1 receptors show that the pI 6.8 isoform is the AT1 receptor (the A and B forms have the same Smith et al., 1992) . Most of the known physiological functions of angiotensin II seem to be mediated via the AT1 receptor pI; Barker et al., 1993) , and that the pI 6.3 isoform is the AT2 subtype. There are thus two additional specific angiotensin II (e.g. Ouali et al., 1992) , which is a member of the G-protein linked, seven transmembrane receptor superfamily (Murphy binding proteins in these rat target tissues which are neither AT1 (A or B) nor AT2 receptors (Montiel et al., 1993 (Montiel et al., ). et al., 1991 Sasaki et al., 1991) and exists in two forms, AT1A and AT1B, in rats and mice (Bergsma et al., 1992;  Internalization and recycling may also affect tissue responses differentially. For example, in studies with our monoclonal Sandberg et al., 1992) , but not in humans (Bergsma et al., 1992) . The two AT1 receptors are highly homologous but are antibody to the AT1 receptor, we found that the bulk of the receptor is expressed on the plasma membrane in some cell differentially regulated (Chaki and Inagami, 1992; Jarvis et al., 1992; Kitami et al., 1992) . There is also some functional types (e.g. endothelial cells, smooth muscle cells) but is mostly internalized in others (adrenocortical cells, epithelial cells; evidence for the existence of more AT1 type receptors (Chaki and Inagami, 1992; Jarvis et al., 1992; Song et al., 1992;  see Figure 2 ). In adrenal glomerulosa cells, the inositol trisphosphate (IP3) pathway can be evoked at the plasma Tsutsumi and Saavedra, 1992) . The AT2 receptor is also a seven transmembrane receptor, though with a unique mode of membrane, but internalization is specifically required for activation of protein kinase C (Kapas et al., 1994) . signal transduction: it does not bind G-protein, but instead it has phosphotyrosine-inhibiting activity (Bottari et al., 1991;  The existence of additional binding proteins, as well as different receptor isoforms, and their internalization, processing Kambayashi et al., 1993; Mukoyama et al., 1993; Tzuzuki et al., 1994) . There is some functional evidence that there may and recycling, and different mechanisms of intracellular signalling may therefore all contribute to this separation of function be more than one type of AT2 receptor (Tsutsumi and Saavedra, 1992) . The widespread incidence of the AT2 receptor may and discrimination between systemic and tissue RAS. This does not, however, exclude the possibility that other mechansuggest that it has specific roles, and this view has supporters (Brechler et al., 1993) . However, this concept has not been isms exist, and evidence has been presented in the mucosa of the rat uterus for a physical barrier to the movement of enhanced by recent observations in mice bearing a disrupted gene coding for the AT2 receptor, which, though showing angiotensin II (and other substances) which would limit its availability to specific cell types (Andrade et al., 1993) . some changes in vascular function and behaviour, appear to reproduce and develop flawlessly (Hein et al., 1995; Additionally, the extent of angiotensin II generation may be precisely limited to specific sites within the tissues, for example et al., 1995) , despite the abundance of AT2 receptors in the ovary and uterus, and in the fetus of normal animals through binding or sequestration of renin and/or prorenin, and it is conceivable that a recently described renin and prorenin (Timmermans et al., 1993 ; also see below). Another possibility, however, is that this receptor is concerned with programmed binding protein may serve such a function (Sealey et al., lies mainly within the cytoplasm and/or nucleus. Such intracellular staining suggests receptor internalization, as a result of stimulation by locally generated angiotensin II (Vinson et al., 1995a; Saridogan et al., 1996a) . Original magnification ϫ1000. ( Deschepper et al., 1986; Dzau et al., 1987a,b; Hellmann et al., 1988) , and renin itself has been identified in the Leydig 1996). In addition, it has been suggested that some generation cells of the rat and human testis (Pandey et al., 1984 ; Naruse of angiotensin II may even be intracellular (Pandey et al., et al., 1985; Deschepper et al., 1986; Dzau et al., 1987b) . In 1984), although other evidence, at least in the adrenal, suggests rats, testicular renin is diminished in hypophysectomized that intracellular angiotensin II reflects uptake from the extraanimals and increased by human chorionic gonadotrophin cellular compartment, and that most angiotensin II is formed (HCG) treatment (Naruse et al., 1984) , and it is thus extracellularly (Urata et al., 1994a) . independent of circulating renin. As in other parts of the reproductive tract, and in non-kidney tissue generally, prorenin is also abundant, and may even be secreted by the testis The RAS in the reproductive tract (Sealey and Rubattu, 1989) , although secretion of active renin Male reproductive system into the spermatic vein was detected only in subjects treated with HCG (Okuyama et al., 1988a) . (Pro)renin mRNA and small amounts of angiotensinogen mRNA have been isolated from rat and mouse testes A testis-specific ACE isozyme exists which arises from a strong testis-specific promoter within the 12th intron of the plasma prorenin concentrations are directly correlated with the number of ovarian follicles and plasma oestradiol and ACE gene (Zhou et al., 1995 (Zhou et al., , 1996 . This form of ACE is approximately half the size of the somatic isozyme, having a progesterone concentrations in stimulated cycles (Itskovitz and Sealey, 1987; Sealey et al., 1987) . A relationship between 66 amino acid sequence unique to the isozyme, the remainder being identical to the C-terminus of the somatic form (Ehlers active renin concentration and oocyte maturity has been suggested by some authors (Sato, 1991) but not others (Paulson et al., 1989; Langford et al., 1991) . Expression of this smaller form of ACE is limited to Leydig cells and developing et al., 1989) . However, further direct evidence for an ovarian source stems from the lack of any increase in plasma prorenin spermatozoa (Pandey et al., 1984; Brentjens et al., 1986) , and the activation of expression in rats of this truncated form of in pregnant women with ovarian failure, who have conceived using donated eggs (Derkx et al., 1987; Sealey et al., 1987) . ACE is very marked at puberty (Cushman and Cheung, 1971; Strittmatter et al., 1985; Costerousse et al., 1994) . The testis On the other hand, higher prorenin concentrations in the uterine vein than in the radial artery in pregnant women at term suggests RAS appears to be regulated by sex hormones as well as by gonadotrophin (Dzau et al., 1987a; Okuyama et al., 1988a,b) .
an additional utero-placental contribution (Brar et al., 1986) . In other species, for example the cat, it may be that the Angiotensin II generation has been directly demonstrated in the human testis (Okuyama et al., 1988b) , and angiotensin II reproductive tract does not secrete renin at all, but high concentrations are retained within the tissues, and are regulated concentrations, as well as those of active renin, were increased in internal spermatic vein plasma from patients receiving HCG with the reproductive cycle, thus emphasizing the role of the tissue RAS as a paracrine, not endocrine, system (Rubattu (Okuyama et al., 1988a) .
Both testis and somatic ACE isozymes are present in the et al., 1991) . Angiotensinogen is present in human follicular fluid at epididymis, and they are separately regulated (Strittmatter and Snyder, 1984; Strittmatter et al., 1985) : it is likely that here similar or lower than plasma concentrations (Glorioso et al., 1986; Derkx et al., 1987) and at various sites in the rat ovary, the smaller isozyme component is in fact derived from the testis or the spermatozoa (Williams et al., 1995) . Angiotensin including follicles, corpora lutea and the germinal epithelium (Thomas and Sernia, 1990) : angiotensin II immunostaining II is secreted in vitro by epithelial cells from the rat epididymis, where it is known to have specific actions on ion transport was detected in corpora lutea and stromal and thecal cells of larger follicles (Lightman et al., 1988a) . ACE is localized to Uchendu, 1990, 1991; Wong et al., 1990b) . Prorenin is present in human seminal fluid (Gupta et al., 1995;  the germinal epithelium surrounding corpora lutea and granulosa cells of some follicles in the rat ovary (Speth and Husain, Mukhopadhyay et al., 1995) , and renin (and its regulation by testosterone) has been described in mouse coagulating gland 1988). It is also present in ovaries of pregnant and postpartum rats, though ACE activity does not show any significant change (Kon et al., 1995) . The presence of ACE has been reported in the rat vas deferens (Hohlbrugger et al., 1982) . during these periods (Howard and Husain, 1992) . Angiotensin II-like immunoreactivity has been shown to be Ovary~1 0 times higher in human follicular fluid than in plasma, and is correlated with renin activity: both increase significantly in In the ovary, prorenin production and renin and ACE have been identified by hybridization, immunological and enzyme gonadotrophin-stimulated cycles (Culler et al., 1986; Lightman et al., 1987; Sato, 1991) . In addition, peritoneal fluid angioassay methods (Derkx et al., 1987; Itskovitz and Sealey, 1987; Metzger et al., 1988; Howard and Husain, tensin II is increased in the peri-ovulatory period in stimulated cycles (Delbaere et al., 1996) ; plasma renin may also rise 1992), and angiotensin II immunostaining has been detected in corpora lutea and stromal and thecal cells of larger follicles (Beerendonk et al., 1996) . The distribution of angiotensin II in theca and hilar cells in the follicular phase, and also in from rat ovaries (Lightman et al., 1988a) . In rats, ovarian total renin content has been shown to vary with the state of the granulosa cells at midcycle, is similar to that of renin (Palumbo et al., 1989) . HCG also enhances the secretion rate of angiooestrous cycle, being highest at oestrus, though the ratio of active renin to inactive prorenin remained constant at about tensin II from the perfused rabbit ovary (Yoshimura et al., 1994) . 3:1, contrasting with plasma, in which 90% was in the prorenin form . Further activation of ovarian renin Uterus was found in pregnancy and in postpartum animals (Howard and Husain, 1992) . High concentrations of active renin were Evidence also exists for a discrete uterine RAS. High concentrations of (pro)renin are found throughout the female reproductive also reported in corpora lutea from pregnant cattle and sheep (Hagemann et al., 1993) . In the human ovary, prorenin (and tract (Sealey and Rubattu, 1989) , and in the uterus its primary sources are the endometrium and decidua (Hsueh, 1988) , in renin) originates in thecal cells (Hsueh, 1988; Paulson et al., 1989) , and it is prorenin that is secreted into the ovarian vein which renin and prorenin occur in similar amounts (Warren et al., 1982) . Both renin and prorenin increase in the myo- (Paulson et al., 1988) . Plasma prorenin concentration changes dynamically through the menstrual cycle, being highest during metrium during pregnancy (Warren et al., 1982) , though this may reflect uptake (Nielsen et al., 1995) . Renin mRNA is the luteinizing hormone (LH) surge and in pregnancy, or following HCG treatment (Itskovitz and Sealey, 1987; Sealey present in human decidua and endometrium, and renin is secreted in vitro (Shaw et al., 1989; Duncan et al., 1990; Sealey and Rubattu, 1989; Ganong, 1995) . LH also stimulates prorenin secretion in bovine theca cells in vitro Poisner et al., 1990) . Angiotensinogen is present, but its mRNA has not been detected, leading to speculation that this (Brunswigspickenheier and Mukhopadhyay, 1990) . In women, (Khanum and Dufau, 1988) . Infusion of prorenin into rhesus monkeys was shown et al., 1995) . In pigs and cattle, active renin was found to to markedly depress plasma testosterone concentrations, in predominate in the uterus, though at relatively low concentraassociation with other cardiovascular and hormonal effects, tions compared with the pregnant ovary in these species though this may be indirect, in view of the evidence that (Hagemann et al., 1993) . High concentrations of ACE occur suggests the existence of a blood-testis barrier (see below; in the blood vessels throughout the sheep reproductive system, Lenz et al., 1990) . and, interestingly, in the Fallopian tube epithelium (Moeller In the epididymis, angiotensin II receptors are present in et al., 1996) . the epithelial cells lining the lumina (Vinson et al., 1995a) , The distribution of the components of the RAS in the and are involved in the regulation of electrolyte and fluid flux reproductive tract is summarized in Tables I and II. across the epithelium. Using confluent monolayers from the rat cauda epididymis, it was shown that both angiotensin I Specific roles for tissue RAS in reproduction and angiotensin II elicited transient increases in short circuit What are the specific functions of the tissue RAS that would current when applied either basally or apically, though the be inappropriately met by the systemic RAS? In the case of response to angiotensin I was eliminated in the presence of an both the adrenal and the cardiovascular RAS, to which perhaps ACE inhibitor and that to both peptides by a peptide angiotensin most attention has been paid, it has been proposed that the II antagonist. The concentration of angiotensin II in the luminal systemic RAS is concerned with acute homeostatic functions, content in the cauda epididymis was found to be 13 nmol/l, whereas the tissue system exercises trophic control (Becker near the threshold for the effects observed. Because most of et Dzau, 1993; Swales and Samani, 1993) . It is the ACE activity in the epididymal content derives from thought this would be consistent with the likely dynamics of spermatozoa, the authors concluded that the spermatozoa angiotensin availability from the two sources.
themselves participate in the regulation of their fluid New functions for angiotensin II have been identified in the environment. reproductive tract that are quite different in nature.
Using a specific monoclonal antibody, we identified AT1 receptors in several components of the reproductive tract, Testis, epididymis and spermatozoa including vascular and secretory epithelia (Vinson et al. , Autoradiographic studies combined with ligand binding assay 1995a). In addition, however, we also identified the receptor revealed that angiotensin II receptors are present in Leydig in the tails of developing rat spermatozoa, and in ejaculated cells, but no specific binding was revealed in seminiferous rat and human spermatozoa (Vinson et al., 1995b) . This tubules in rat, rhesus and cebus monkey, or human testes receptor is functional, and exposure of human spermatozoa to (Millan and Aguilera, 1988) , though this contrasts with data angiotensin II enhances the percentage of motile spermatozoa obtained using a monoclonal antibody to the AT1 receptor and also stimulates other parameters of motility. All of these (see below). In rats, ligand binding was strongest in newborn actions of angiotensin II are inhibited by the specific AT1 animals, but declined towards adult age, apparently reflecting antagonist losartan (Vinson et al., 1996) . In addition, the changes in the interstitial volume as a proportion of whole acrosome reaction is inhibited by captopril (Foresta et al., testis volume. The data strongly suggest a role for angiotensin 1991). Further evidence of the role of angiotensin II in male II in the regulation of androgen secretion, subsequently borne fertility stems from studies on mice with a disrupted gene coding for both the somatic form of ACE and the testisout by the finding that angiotensin II inhibits cyclic AMP and Saridogan et al. (1996b) specific form. In these animals, males have reduced fertility, the addition of LH to the culture medium increases the expression of AT2 receptors on bovine theca cells despite having normal developed testes, spermatozoa and mating behaviour (Krege et al., 1995) and apparently unaf- (Brunswigspickenheier and Mukhopadhyay, 1992) . Earlier work suggested that angiotensin II stimulates ovarian fected sperm motility (Esther et al., 1996) , so clearly this particular parameter is regulated multifactorially. Nevertheless, oestrogen production Speth and Husain, 1988; Nemeth et al., 1994) . Any effect is, however, complicanother interpretation of the tissue RAS present in both the male and female reproductive tract is that it exists to provide ated, possibly reflecting antagonism between AT1 and AT2 receptor function. Thus, angiotensin II alone or in combination angiotensin II to spermatozoa throughout their transit.
Three actions of angiotensin II on the vas deferens have with endothelin-1 and/or atrial natriuretic peptide stimulated in-vitro synthesis of oestradiol and progesterone by granulosa been reported: it stimulates prostacyclin release in rabbit tissue and electrical and contractile activity in the rat. All three cells from immature rat ovaries treated with pregnant mare's serum gonadotrophin (PMSG) (Usuki et al., 1993) ; angiotensin effects are mediated by the AT1 receptor subtype (Catalioto et al., 1994; Sum and Cheung, 1995) .
II also stimulated oestradiol, but not progesterone, production in perfused rabbit ovaries, probably by inducing prostaglandin Ovary production (Yoshimura et al., 1993) . However, in separated theca and granulosa cells from rabbits pretreated with PMSG, Angiotensin II receptors, mostly of the AT2 subtype, are present in granulosa and theca interna cells of a subpopulation angiotensin II was in fact found to inhibit oestrogen synthesis in both cell types, while increasing testosterone production by of follicles in the rat ovary (Speth et al., 1986; Husain et al., 1987; Lightman et al., 1988b; Speth and Husain, 1988;  Pucell the theca cells (Feral et al., 1995) . Angiotensin II had no effect on in-vitro progesterone secretion from human luteinized et , 1991 Brunswigspickenheier and Mukhopadhyay, 1992) . Ovarian angiotensin II receptors display a cyclical granulosa cells (Rainey et al., 1993) though in-vivo ACE inhibition with captopril raised serum oestradiol and lowered pattern of variation during the rat oestrous cycle, and angiotensin II receptor-containing follicles are mainly atretic (Daud progesterone concentrations in stimulated cycles (Morris et al., 1995a) . In further contrast, angiotensin II inhibited the LHet al., 1988) , which is perhaps consistent with the proposed role of AT2 receptors in apoptosis referred to above. However, stimulated progesterone synthesis and 3β-hydroxysteroid dehydrogenase induction in a dose-dependent manner in porcine other data suggest that AT1 receptors are also expressed in rat luteal cells (Pepperell et al., 1993) . In-vitro studies show that granulosa cells; these effects were blocked by saralasin (Li et al., 1995) . Although this variability of the effect of angiorevealed that enalapril inhibits the gonadotrophin-stimulated rise in angiotensin II while increasing ovarian oestradiol tensin II on ovarian steroidogenesis may be attributable to species and experimental differences, it is possible to speculate production (Morris et al., 1995d) ; it may also prevent the development of OHSS (Morris et al., 1995c) . that all of these different actions may in fact be part of the overall role of angiotensin II, and depend on the stage of the The relationship of increased peritoneal angiotensin II concentrations with the peri-ovulatory period, however, suggests ovarian cycle, other hormonal parameters, and, particularly, the potential antagonism between AT1 and AT2 receptor function.
the possibility that the significance of ovarian angiotensin II production is not connected with intra-ovarian events alone. Although earlier reports suggest that angiotensin II was not involved in ovulation (Daud et al., 1989) , angiotensin II was It is certainly possible that the injection of angiotensin II from the ovary into the Fallopian funnels at the time of ovulation shown to stimulate ovulation in the rabbit (Yoshimura et al., 1993) and the angiotensin II antagonist saralasin inhibited also facilitates ovum transport and fertilization, in view of the presence of angiotensin II AT1 receptors in both Fallopian ovulation in perfused rat ovaries, although converting enzyme inhibitors did not (Peterson et al., 1993a,b) .
tube and uterine epithelial cells, and in spermatozoa (Vinson et al., 1995b (Vinson et al., , 1996 Delbaere et al., 1996; Saridogan et al. , Another role which has been ascribed to the ovarian RAS is its possible involvement in follicular atresia (Nemeth et al., 1996a,b) . 1994). The findings that the angiotensin II receptors are Fallopian tube and uterus mainly expressed in atretic follicles , that concentrations of prorenin are higher in atretic follicles than
Immunoperoxidase staining showed that the epithelium of the Fallopian tube, like epithelia in other ductal systems (for in others (Mukhopadhyay et al., 1991) and that renin and angiotensin II are present in the granulosa cells of atretic example the breast), stained strongly for the presence of AT1 receptors, though the underlying tissue did not ( Figure 3 ) follicles but only in theca cells of developing follicles suggest that the ovarian RAS may be involved in this process (Palumbo (Saridogan et al., 1996a) . The presence of AT1 receptors was confirmed by ligand binding studies, which additionally showed et al., 1993). Clearly, if AT2 receptors are involved in apoptosis, then a similar mechanism may account for follicular atresia.
that, like the uterus, the Fallopian tube also contains AT2 receptors. AT1 receptors were found in highest concentration However, compared with patients on a normal diet, numbers of follicles were reported to be increased when women in the ampullary segment of the Fallopian tube, with lower concentrations in the fimbrial and isthmus regions, as seen by undergoing ovarian stimulation consumed a low sodium diet, which suggests a relationship with circulating renin/prorenin, ligand binding and immunocytochemistry and by immunoblotting, which revealed a single immunoreactive protein, of~60 since these concentrations were increased, whereas ovarian renin and prorenin were unchanged. Numbers of retrieved kDa. In addition, ligand binding and immunocytochemistry also showed that AT1 concentrations were very much lower oocytes and fertilization rates were unaffected (Beerendonk et al., 1996) .
in Fallopian tubes from postmenopausal women, and, furthermore, staining was also stronger in the proliferative phase Immunocytochemical staining of ovaries from polycystic ovary syndrome (PCOS) patients shows a similar pattern to than in the secretory phase, strongly suggesting that receptor expression is hormonally controlled. Functional studies that seen in atretic follicles. Polycystic ovaries show an increased expression of renin and angiotensin in both theca revealed that, in contrast for example to noradrenaline, angiotensin II had no effect on tubal myosalpingeal function. It did, and granulosa cells (Palumbo et al., 1993) , and particularly in the stromal cells. Patients with PCOS also have higher baseline on the other hand, stimulate ciliary beat frequency in tubal epithelial cells maintained in primary culture. This action concentrations of plasma prorenin compared to normal controls, and in both groups low active renin concentrations are associwas inhibited by losartan, but not by the AT2 antagonist CGP42112B (Saridogan et al., 1996a) . ated with better ovulatory responses to clomiphene citrate (Morris et al., 1995b) . These findings suggest that the RAS The presence of angiotensin II receptors in the uterus has long been recognized, though previously thought to be only may play a role in the pathogenesis of the syndrome, though there is presently no information on the distribution of angioof type AT2 in the human (Whitebread et al., 1989) , but the role of angiotensin II has not clearly been defined. However, tensin II receptors in polycystic ovaries.
There are also suggestions that the ovarian RAS may be in rat uterus, AT1 receptors are present in uterine smooth muscle cells (Hsieh et al., 1989; Scanlon et al., 1990) , and involved in the development of ovarian hyperstimulation syndrome (OHSS), since plasma renin concentration and renin angiotensin II induces uterine contractions (Calixto and Rae, 1991; Olins et al., 1992) in addition to its vasoactive effects activity are increased and may be associated with the severity of the disease (Navot et al., 1987; Ong et al., 1991) . High (Allen et al., 1991) . Uterine contractions are inhibited by the specific AT1 antagonist losartan. concentrations of prorenin (Rosenberg et al., 1994) and angiotensin II have also been detected in the The anti-AT1 antibody identifies the receptor in the luminal epithelium of the rat uterus as well as in muscle and vascular ascites of patients with OHSS. Increases in plasma renin activity may, however, be secondary to vasodilatation (Balasch sites (Vinson et al., 1995a) , and it is distinctly possible that angiotensin II also has specific actions on the functions of et al., 1991, 1994) , and therefore the source of renin may be renal. These data, which suggested a possible role for RAS in these cells. More recently, in agreement with other work (Ahmed et al., 1995) , we have shown that the AT1 receptor OHSS, have led some groups to study the effects of ACE inhibitors on experimental OHSS in rabbits. These studies subtype is indeed also present in the non-pregnant human uterus, albeit confined to the luminal and vascular epithelium electrolyte and hormone secretion and (iii) control of tubular transport by epithelial ciliary/flagellar motion. (Saridogan et al., 1996b) . This specific localization may be The conclusion for reproductive physiology is therefore that the reason earlier authors reported its absence: it is certainly angiotensin II has a crucial role which, inter alia, offers new not present in the normal myometrium. As yet the functional insight into fundamental mechanisms and the possibility of significance of the receptor in this site has not been addressed, new routes to therapeutic intervention both for improving but in view of the seemingly almost universal presence of the fertility and, potentially, for reducing it as well. AT1 receptor in secretory epithelia, it is possible to speculate what such a role might be (see below). It is also highly pertinent that AT1 receptor expression appears to be hormonally Postscript: reproductive effects of administered ACE regulated in these sites, increasing during the proliferative inhibitors phase and declining as the secretory phase progresses (Ahmed et al., 1995; Saridogan et al., 1996a; Figure 4) . The expression One question that these studies, taken together, all raise is whether the beneficial effects of ACE inhibition therapy on of AT1 mRNA in endometrial glands and blood vessels led to cardiovascular function may be accompanied by unwanted speculation that these receptors may be involved in endometrial side-effects on the reproductive system. In fact, there are regeneration after menstruation, acting both as mitogenic and known to be profound differences in the responses to ACE angiogenic mediators (Ahmed et al., 1995) . In rats, changes inhibition in the tissues compared with those in plasma or associated with decidualization are inhibited by converting kidney. Thus, administration of perindopril to rats resulted in enzyme inhibition (Squires and Kennedy, 1992) .
pronounced inhibition of plasma and kidney ACE activity, Angiotensin II does not induce contractions of myometrial with less effect in lung or aorta (Jackson et al., 1988a) . Testis strips from non-pregnant women (Cox et al., 1996) , in which ACE was unaffected under the same conditions. At low doses, (as noted) most angiotensin II receptors are of the AT2 subtype only ACE in those brain structures outside the blood-brain (Whitebread et al., 1989; Criscione et al., 1993) . However, barrier were affected, though at higher concentrations perindopthere is a 92% decrease in total receptor concentration in ril appeared to be able to cross the barrier. The kinetics of pregnancy, as a result of which AT1 receptors become prebinding appear to be similar for testis and somatic ACE, so dominant, though not actually increasing in number. Myothat the answer would appear to be that the blood-testis barrier metrial strips from pregnant women become responsive to is also impenetrable to the drug (Jackson et al., 1988a,b ; angiotensin II, and this effect is blocked by losartan (Cox Johnston et al., 1988; Wong and Uchendu, 1990; Sakaguchi et al., 1996) . Myometrial responsiveness is increased further et al., 1988) . in labour, suggesting that the RAS may have a role in initiation This would account therefore for the general finding that, of normal and premature labour. administered systemically, ACE inhibitors have little or no effect on sperm function. Administered locally, however, the acrosome reaction (though not motility or viability in these Conclusions and hypotheses particular experiments) was shown to be inhibited by captopril With all of this information it is now clearly apparent that: (i) (Foresta et al., 1991) . several tissues contain all of the elements required for the An alternative explanation is offered by studies on the ovary, local generation of angiotensin II, and such systems are in which, as discussed, the evidence supports the concept that regulated separately from the systemic RAS; (ii) the locally angiotensin II participates in the regulation of ovulation. generated angiotensin II acts in a paracrine fashion to elicit However, since inhibition of ovulation was seen with saralasin responses which may be concerned with tissue growth and in the perfused ovary system, but converting enzyme inhibitors repair, or with other functions which are highly specific, and did not inhibit ovulation (Peterson et al., 1993a,b) , the authors which are not necessarily related to the functions of the suggested that angiotensin I (or angiotensin fragments) may systemic RAS; (iii) mechanisms exist to ensure that the interact sufficiently with the receptors to evoke ovulation, or paracrine target cells respond in a specific manner to locally alternatively that angiotensin II may be selectively produced generated angiotensin II, and differently (if at all) to the from angiotensinogen by plasminogen activators, rather than systemic RAS.
through the classical RAS (Peterson et al., 1993a) , or, presumIt is the overall significance of angiotensin II as a universal ably, from angiotensin I by the action of chymase. organizer and regulator of tissue function that now draws attention. Our own work suggests that the effects of angiotensin on particular organs and systems, such as the adrenal, the References testis and the reproductive tract, reflect the general importance context, the adrenal cortex, as well as the germinal cell line, Invest., 96, [848] [849] [850] [851] [852] [853] [854] [855] [856] [857] merely reflect highly specialized epithelial forms. In this way, Aiyar, N., Griffin, E., Edwards, R. et al. (1993) Characterization of bovine ovary angiotensin II receptors using subtype-selective antagonists.
the presence of RAS in many organs is easier to interpret, and 
